Medicare Enrolled
Dr. Michael Santomauro, M.D
Urology Physician · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Santomauro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santomauro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Santomauro
Dr. Michael Santomauro is an urology physician in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Santomauro performed 3,071 Medicare services across 1,059 unique beneficiaries.
Between the years covered by Open Payments, Dr. Santomauro received a total of $51,877 from 54 pharmaceutical and/or device companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Santomauro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 27% volume in CA
$51,877 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,071
Medicare services
Top 27% in CA for urology physician
1,059
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,500 | $19 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
253 | $97 | $600 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
201 | $2 | $8 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
168 | $51 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
146 | $66 | $440 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
103 | $8 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $121 | $780 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
82 | $60 | $340 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 73 | $132 | $720 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $105 | $545 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
51 | $201 | $1,230 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
46 | $12 | $80 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
41 | $38 | $240 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
33 | $3 | $20 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
33 | $28 | $180 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
31 | $125 | $730 |
| Injection, tobramycin sulfate, up to 80 mg | 30 | $2 | $15 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
28 | $75 | $440 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $197 | $1,180 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
24 | $50 | $310 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
18 | $105 | $600 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
16 | $114 | $640 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $95 | $540 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$51,877
Total received (2018-2024)
Avg $7,411/year across 7 years
Top 6% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
334
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$42,603 (82.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,274 (17.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,229
2023
$2,855
2022
$2,721
2021
$9,862
2020
$9,987
2019
$4,258
2018
$17,965
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$2,250
Dendreon Pharmaceuticals LLC
$431
Axonics, Inc.
$270
BIOTISSUE HOLDINGS INC.
$203
Medtronic, Inc.
$164
Teleflex LLC
$148
PROCEPT BioRobotics Corporation
$139
ABBVIE INC.
$115
COLOPLAST CORP
$70
Sumitomo Pharma America, Inc.
$61
Astellas Pharma US Inc
$60
PFIZER INC.
$54
Bayer Healthcare Pharmaceuticals Inc.
$53
Janssen Biotech, Inc.
$32
Becton, Dickinson and Company
$31
IMMUNITYBIO, INC.
$29
ACCORD HEALTHCARE, INC.
$23
Myriad Genetic Laboratories, Inc.
$21
Telix Pharmaceuticals
$20
Tempus AI, Inc
$19
Calyxo, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Top 3 companies account for 69.8% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$40,446
INTUITIVE SURGICAL, INC.
$2,250
Medtronic, Inc.
$1,112
Dendreon Pharmaceuticals LLC
$912
Axonics, Inc.
$725
Janssen Biotech, Inc.
$700
Bayer HealthCare Pharmaceuticals Inc.
$425
Teleflex LLC
$381
Merck Sharp & Dohme LLC
$343
UroGen Pharma, Inc.
$337
Myovant Sciences Inc.
$289
Bayer Healthcare Pharmaceuticals Inc.
$257
Boston Scientific Corporation
$257
Astellas Pharma US Inc
$251
ABBVIE INC.
$239
PROCEPT BioRobotics Corporation
$224
BIOTISSUE HOLDINGS INC.
$203
AstraZeneca Pharmaceuticals LP
$195
Myriad Genetic Laboratories, Inc.
$194
PFIZER INC.
$185
Progenics Pharmaceuticals, Inc.
$184
Medtronic USA, Inc.
$183
Sumitomo Pharma America, Inc.
$154
Janssen Scientific Affairs, LLC
$136
Blue Earth Diagnostics Limited
$135
Photocure Inc
$118
Antares Pharma, Inc.
$106
ABC Home Medical Supply, Inc.
$105
AbbVie Inc.
$85
COLOPLAST CORP
$82
Foundation Medicine, Inc.
$54
ACCORD HEALTHCARE, INC.
$47
Endo Pharmaceuticals Inc.
$46
Novartis Pharmaceuticals Corporation
$45
Amgen Inc.
$44
Telix Pharmaceuticals
$43
BOSTON SCIENTIFIC CORPORATION
$34
Becton, Dickinson and Company
$31
IMMUNITYBIO, INC.
$29
Tolmar, Inc.
$28
180 Medical, Inc.
$28
Sun Pharmaceutical Industries Inc.
$25
AngioDynamics, Inc.
$24
C. R. Bard, Inc. & Subsidiaries
$23
Accord Healthcare, Inc.
$22
Tempus AI, Inc
$19
Calyxo, Inc.
$19
Supernus Pharmaceuticals, Inc.
$19
Olympus America Inc.
$17
Hollister Incorporated
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
UROGEN PHARMA, INC.
$14
Sagent Pharmaceuticals, Inc.
$13
SRS Medical Systems, Inc.
$13
Top 3 companies account for 84.4% of all-time payments
Associated products mentioned in payments ›
ADVANCE · AKEEGA · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Altis · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CREON · CVAC ASPIRATION SYSTEM · CYSVIEW · Da Vinci Surgical System · ERLEADA · FOUNDATIONONE · GEMTESA · Glydo · ILLUCCIX · INTERSTIM · INTERSTIM ICON · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · MYRISK · Magic 3 · Myrbetriq · NANOKNIFE · NOCDURNA · NURO · Nubeqa · ORGOVYX · PCN Devices · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · Restorelle · Rezum Generator · TLANDO · UPSYLON · UROLIFT · UroCuff · UroLift System · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for urology physician in CA.
Geographic Context
Urology physicians within 10 mi
132
Per 100K population
4.0
County median income
$102,285
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN DIEGO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Santomauro is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Santomauro experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Santomauro performed 1,500 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Santomauro receive payments from pharmaceutical companies?
Yes. Dr. Santomauro received a total of $51,877 from 54 companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santomauro's costs compare to other urology physicians in San Diego?
Dr. Santomauro's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santomauro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in San Diego
Browse urology physicians in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology